You are here

New Study Finds Rapid Uptake of Subcutaneous Injectable in Burkina Faso

A new article published in Global Health: Science and Practice found evidence of a rapid uptake of the subcutaneous injectable in Burkina Faso based on data collected from Performance Monitoring and Accountability 2020 (PMA2020). PMA2020 is the first survey to track programmatic progress of the subcutaneous injectable (also referred to as SC-Injectable, or its commercial name, Sayana Press) at the population and health facility level in Burkina Faso since the method was first piloted in select regions in 2014 and introduced at the national level in 2016. Researchers at PMA2020 found that SC-Injectable prevalence in Burkina Faso almost doubled over a 6-month period. The article entitled, Rapid Uptake of the Subcutaneous Injectable in Burkina Faso: Evidence From PMA2020 Cross-Sectional Surveys was published in March 2018.

Dr. Georges Guiella, Principal Investigator for PMA2020 in Burkina Faso, Drs. Scott Radloff and Yoonjoung Choi, Director and Deputy Director for PMA2020, respectively, and collaborating authors Shani Turke and Hamadou Coulibaly, used data from the third and fourth rounds of data collection (March-May 2016 and November-January 2017, respectively) to analyze the uptake of the SC-Injectable.

The article highlights key findings, including:

  + Over the course of the two survey rounds, the availability of the SC-Injectable at public service delivery points increased from 50% to 85%, driven mainly by increases in availability in the non-pilot regions.

  + Over the course of the two survey rounds, modern contraceptive use (mCPR) among all women remained comparable at 23%, but SC-Injectable prevalence nearly doubled from 1.1% to 2.0%, accounting for 9% of the modern method mix.

  + Although not statistically significant, SC-injectable use was higher among rural women than their urban counterparts (2.1% vs. 1.7%), which may be attributable to the mobilization of more community health workers (CHWs) promoting the method in rural areas.

- In the rural areas of the pilot regions, SC-Injectable use increased from 1.8% to 3.2% over the two survey rounds.

PMA2020 uses innovative mobile technology to support low-cost, rapid-turnaround surveys to monitor key family planning and other health indicators on an annual basis. The program is implemented by local universities and research organizations in 11 countries, deploying a cadre of female resident data collectors trained in mobile data collection. In Burkina Faso, PMA2020/Burkina is led by the Institut Superieur des Sciences de la Population (ISSP) at the Université Ouaga 1 Pr Joseph Ki-Zerbo. Overall direction and support is provided by the Bill & Melinda Gates Institute for Population and Reproductive Health at the Johns Hopkins Bloomberg School of Public Health and funded by the Bill & Melinda Gates Foundation.

Read the full article >

Saturday, March 3, 2018